Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study [0.03%]
在TROPION-PanTumor02一期/二期研究中，Datopotamab deruxtecan治疗三线及以上晚期或转移性三阴性乳腺癌的中国患者疗效和安全性评估
Tao Wang,Yuping Sun,Wenyan Chen et al.
Tao Wang et al.
Background: Despite recent improvements in treatment, outcomes for patients with pretreated, advanced triple-negative breast cancer (TNBC) remain poor. We present results from the phase I/II TROPION-PanTumor02 study of da...
Chemotherapy-induced peripheral neuropathy in breast cancer: a narrative review [0.03%]
乳腺癌的化疗诱导外周神经病变：叙述性综述
Michael Brodsky,Mumtu Lalla,Sun Oh et al.
Michael Brodsky et al.
Background and objective: Chemotherapy-induced peripheral neuropathy (CIPN) remains a major, unresolved complication of breast cancer therapy, often leading to treatment modifications and enduring functional impairment. T...
Magnetic resonance imaging in breast cancer management: current applications, limitations, and future directions [0.03%]
乳腺癌诊疗中的磁共振成像：目前的应用、局限性及未来方向
Daniel C Sasson,Arielle L Sasson,Donna A Eckstein et al.
Daniel C Sasson et al.
Magnetic resonance imaging (MRI) has emerged as a cornerstone of breast cancer management, demonstrating superior sensitivity compared to mammography and ultrasound, particularly for high-risk screening and the evaluation of dense breast ti...
Efficacy and safety of T-DXd in patients with HER2-positive and HER2-low metastatic breast cancer: a real-world study [0.03%]
T-DXd治疗HER2阳性及低表达转移性乳腺癌患者的有效性和安全性：一项真实世界研究
Rongrong Lu,Mengyao Zha,Kai Cao et al.
Rongrong Lu et al.
Background: The DESTINY-Breast trials established trastuzumab deruxtecan (T-DXd) as a treatment significantly improving outcomes in human epidermal growth factor receptor 2 (HER2)-positive and HER2-low metastatic breast c...
The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study [0.03%]
小剂量长春瑞滨联合安罗替尼治疗HER2阴性晚期乳腺癌的疗效和安全性：前瞻性单臂临床研究
Xinli Wang,Ting Yang,Junmei Zhang et al.
Xinli Wang et al.
Background: In the era of chronic cancer management, second-line treatment for HER2-negative (HER2-) advanced breast cancer demands convenient and safe therapeutic options. Vinorelbine tartrate soft capsules are an oral c...
The impact of breast cancer on cosmetic breast augmentation outcomes and screening challenges in patients with implants: a literature review [0.03%]
乳房癌对其它乳腺美容扩充效果及植入物患者筛查挑战的的影响：文献回顾
Denis Souto Valente,Felipe Jorge Marques Carvalho da Costa,Bruno Henrique Volkmann et al.
Denis Souto Valente et al.
Background and objective: Breast augmentation remains one of the most common aesthetic surgical procedures worldwide, offering significant psychological benefits. However, the presence of breast implants introduces unique...
Josephine Ngugi,Janhavi Venkataraman,Kefah Mokbel
Josephine Ngugi
Radiotherapeutic management of brain metastases in patients with breast cancer: a narrative review [0.03%]
乳腺癌患者脑转移的放射治疗管理：叙事综述
Bing Sun,Jinbo Yue
Bing Sun
Background and objective: The incidence of brain metastasis (BM) has increased alongside improved survival among breast cancer patients. Brain metastasis in breast cancer (BCBM) patients pose a significant challenge due t...
Extent of resection in breast conserving surgery after neoadjuvant chemotherapy: a literature review [0.03%]
新辅助化疗后保乳手术的切缘评估：文献综述
Rey Benjamin Ick Joson,Tessa Ying Zhen Tan,Geok Hoon Lim
Rey Benjamin Ick Joson
Background and objective: Neoadjuvant chemotherapy (NACT) could cause tumor shrinkage and result in a higher rate of breast conservation. However, the extent of resection in breast conserving surgery (BCS) following NACT ...